. Furthermore, hypoof corticosteroids. Preoptic lesions adminis-thalamic norepinephrine (NE) metabolism was tered in rats impaired mitogen-induced lym-altered by injection of an antigen or products phocyte blastogenesis (Roszman et al, 1982) . of activated T-cells (Besedovsky et al, 1983b) . These lesions in the rat brains were also Carlson et al. (1987) found that at the time the associated with a decreased splenic natural plaque-forming cell response peaked, NE killer activity (Cross et al, 1984) . These data decreased in the paraventricular nucleus (PVN) suggest a neuroendocrine pathway that is of the hypothalamus, whereas serotonin (5-capable of modulating immune function.
hydroxytryptamine, 5-HT) was decreased in the lymphocyte reactivity at peripheral sites rather than in the brain, as a limited penetration of 5-HT occurs across die blood-brain barrier. Interferon-Y-induced phagocytosis and phytohemagglutinin (PHA)-induced y-interferon synthesis were altered by either 5-HT or dopamine (Andrade-Mena et al, 1987; Sternsberg et al, 1987) . McCorkle et al. (1984) and Edens et al. (1987a,b) found that the levels of 5-HT, DA, and NE were depressed significantly in the brain, spleen, thymus, and bursa of Fabricius of turkey poults infected with Bordetella avium, a mild upper respiratory pathogen that causes rhinotracheitis. This finding stimulated investigations of the effects of biogenic amines on avian immune responses. The PHA wattle response in chickens, a response mediated by T-cells (McCorkle et al, 1979) , was significantly depressed by 5-HT, DA, or NE given 30 min prior to PHA administration (Lukacs et al, 1987) . Using the same single-dose treatment, the leukocyte migration response was enhanced by 5-HT but suppressed by DA or NE (McCorkle et al, 1990) . Continuous administration of 5-HT at 100 ng/h or DA at 1 ug/h suppressed the PHA wattle response but enhanced leukocyte migration (McCorkle and Taylor, 1990a,b) .
These earlier experiments investigated the monoamine effects on avian cellular immunity. So far, no studies have examined the possible effects of monoamines on antibody responses in chickens. Therefore an investigation was undertaken to determine whether in vivo and in vitro 5-HT and DA treatments would modulate chicken plaque-forming cells produced in response to SRBC.
MATERIALS AND METHODS

Animals
Six-week-old mixed sex New Hampshire chicks of Line UNH105 were used in the present study. 
Antigen, Monoamines, and Antagonists
Sheep red blood cells from a single source were collected in Alsever's solution. Cells were washed three times and were diluted to a 5% suspension in .9% saline. Serotonin, DA, apomorphine, a Di receptor antagonist, and metoclopramide, a D 2 receptor antagonist (Kilpatrick et al, 1986) were used 3 for in vivo and in vitro treatments. Preliminary studies were used to determine the levels of monoamines and antagonists to be used for in vivo and in vitro experiments.
Li Vivo Monoamine Treatment and Plaque Assay
The 5-HT and DA were injected intravenously at 100 (ig/kg of body weight and 1 mg/kg of body weight, respectively, into two replicates of 10 chicks each. Twenty control chicks in two replicates were injected with sterile saline. Thirty minutes after monoamine administration, 1 mL of the 5% SRBC suspension was injected intravenously for antigenic stimulation. Chicks were killed by cervical dislocation and spleens removed 5 days after SRBC injection. Cells were collected in Minimum Essential Medium (MEM) by passing the spleens through a stainless steel screen. The cell suspensions were washed three times in MEM, assessed for viability by the trypan blue exclusion test (Tennant, 1964) and adjusted to a concentration of 10 6 viable cells per milliliter of MEM. In a test tube, 150 uL of MEM, 100 uX of the lymphocyte suspension, 25 uL of 18% SRBC, and 25 uL of SRBC-absorbed chicken complement were mixed, transferred to modified Cunningham chambers, 4 and sealed with melted paraffin. The chambers were incubated at 37 C for 60 min, after which the number of IgM plaque-forming cells were counted using a stereomicroscope (McCorkle and Leslie, 1983 
In Vitro Monoamine Treatment with Antagonists
Five days after intravenous immunization with SRBC, 15 birds were killed by cervical dislocation and spleens were removed. A cell suspension of 10 6 cells per milliliter of MEM was prepared as described in the in vivo procedure. One milliliter of lymphocytes from each spleen cell suspension was placed in one of two different centrifuge tubes; control and monoamine treatment. The 5-HT (100 ug) or DA (1 mg) was then added to the monoamine tubes. All samples were incubated for 30 min on ice, washed, and resuspended in 1 mL of MEM. Both IgM and IgG plaque-forming cell assays were performed as described above. Each experiment was performed three times.
Six 1-mL splenic cell aliquots from each of 15 different chicks were prepared to test specific antagonists; control, DA, apomorphine (30 ng and 3 ng), and metoclopramide (100 ng and 10 ng). Antagonists were added to each designated tube and incubated for 30 min on ice. Cells were washed and resuspended in 1 mL of MEM. Control and DA treatments were handled in a similar manner without antagonists. The DA (1 mg) was men added to all the tubes except the controls. All samples were incubated for 30 min on ice, washed, and resuspended in 1 mL of MEM. The IgM and IgG plaque-forming cells were quantified as described.
Statistical Analysis
In vivo and in vitro treatment data were evaluated by Student's t test. Analysis of variance was used to assess treatment effects in the antagonist study. Treatment means were compared with the control using the contrast procedure. In addition, antagonists treatments were compared with the DA mean.
RESULTS
Chicken IgM plaque-forming cell numbers were enhanced significantly by in vivo exposure to 100 Jig 5-HT/kg of body weight (Figure 1 ). Plaques increased 53% above the controls after 5-HT injection. However, in vitro exposure to 5-HT had no significant effect on IgM PFC although PFC were increased 19%. The IgG plaque-forming cell numbers were not affected significantly by either in vivo or in vitro treatment with 5-HT (Figure 2 ).
Both in vivo treatment wiui 1 mg DA/kg of body weight and in vitro exposure to DA significantly suppressed IgM plaque-forming cell counts (Figure 3) . Each of these treatments resulted in a 43% plaque-forming cell reduction. In vivo DA treatment reduced IgG counts by 38% and in vitro DA exposure produced 58% lower IgG counts (Figure 4) . Both of these were significant suppressions.
To determine whether receptors on lymphocytes were mediating the monoamine effects, specific antagonists were used in vitro. Antagonists for 5-HT were not tested because in 
DISCUSSION
vitro exposure of splenic lymphocytes to 5-HT did not alter either IgM or IgG plaqueforming cells (Figures 1 and 2) . The IgM and IgG plaque counts were again reduced by in vitro DA treatment. Neither apomorphine, a Yi\ receptor antagonist, nor metoclopramide, a D 2 receptor antagonist, blocked the suppression of IgM or IgG plaques by DA when added to the in vitro system (Figures 5 and 6 ). Metoclopramide at 100 ng/mL produced a significant reduction in IgM counts compared with both the control and the DA treatment. Apomorphine at 30 ng/mL produced a similar effect on IgG counts.
Neuroendocrine alterations can affect the immune system. For example, hypothalamic lesions are associated with reduced lymphocyte blastogenesis and decreased natural killer cell activity in rats (Cross et al, 1980 (Cross et al, , 1984 Roszman et al., 1982) . The reciprocal is true also because immune responses are correlated with neuroendocrine changes. Injection of antigen results in changes in hypothalamic electrical activity and lowered hypothalamic NE or 5-HT levels Carlson et al., 1983) . Moreover, treatment with exogenous monoamines affects immunity as evidenced by reduced antibodies and plaqueforming cells (DeVoino et al., 1975; Jackson et al., 1985) . Evidence for immune-neuroendocrine communication exists in birds. Pathological conditions reduced 5-HT, DA, and NE in the brain of turkey poults infected with Bordetella avium (McCorkle et al., 1984; Edens et al., 1987a,b) . Cellular immune responses in chickens, such as the PHA wattle response or leukocyte migration, are also affected by experimental administration of exogenous monoamines. The PHA wattle response was suppressed by either a single dose or continuous administration of 5-HT or DA (Lukacs et al, 1987; McCorkle and Taylor, 1990a,b) . Serotonin enhanced leukocyte migration by either dosing method (McCorkle and Taylor, 1990a; McCorkle et al., 1990) . However, DA suppressed migration when given as a single dose but enhanced the response when given continuously (McCorkle et al., 1990; McCorkle and Taylor, 1990b) .
To the authors' knowledge, the present study is the first to demonstrate that monoamines can affect avian antibody-mediated immunity. Serotonin significantly enhances IgM plaque formation to SRBC in chickens when given as in vivo injection prior to immunization, but produces no effects after in vitro exposure when tested 5 days later. Neither in vivo nor in vitro exposure with 5-HT affects IgG plaque-forming cells. In vitro exposure of splenic cells was conducted 5 days after antigen injection when the plaqueforming cell responses would be at their peak. Therefore, it is unlikely that 5-HT acts through receptors on B-cells, because 5-HT did not affect the expression of plaque-forming cells when administered in vitro. The in vivo administration of 5-HT may release other hormones such as corticosterone, growth hormone, or prolactin, which could modulate the plaque-forming cell response. In the absence of receptors on plaque-forming cells, the enhanced IgM response to in vivo 5-HT could be due to the action of either 5-HT or a second messenger on antigen presentation, helper cell contribution, cell proliferation, suppressor activity, or subsequent differentiation of B-cells into plaque-forming cells. Dopamine significantly suppresses both IgM and IgG plaque-forming cells after in vivo or in vitro exposure, which suggests the possibility of direct action on B-cells. This question is addressed by the in vitro exposure in the presence of DA antagonists. Incubation with apomorphine or metoclopramide, Di and D2 receptor antagonists, respectively, does not block plaque suppression by DA at the concentrations of antagonists tested. The in vitro suppression of plaque-forming cells by DA, whether direct or through a second messenger, could be the result of enhanced capping of IgG on the surface of plaqueforming cells.
The cells involved in the immune response must operate in an environment containing numerous hormones and neurotransmitters. The importance of these substances may lie in concentration changes of the specific agents, or in their relationship to the concentration of other factors. An essential requirement for their participation in immunoregulation is the presence of receptors for these messengers. In mammals, receptors for corticosteroids, insulin, prolactin, growth hormone, estradiol, testosterone, NE, epinephrine, acetylcholine, and endorphins have been demonstrated on lymphoid or accessory cells (Besedovsky et al., 1983a) . On chicken leukocytes, the existence of receptors for 5-HT, DA, NE, and epinephrine has been suggested by leukocyte migration data (McCorkle et al, 1990 ). The present study provides support for the existence of such receptors on immune cells with the exception of those of the B-cell lineage. The receptor concept is further strengthened by the limited ability of the monoamines to cross the blood-brain barrier and thereby bring about systemic effects.
The chicken's immune response is part of a homeostatic response that is subject to regulatory signals. The present study and the authors' previous work provide evidence that 5-HT and DA have a regulatory role in immunity. The results suggest that this action is mediated by receptors on cells of the immune system. However, it is possible that 5-HT and DA could indirectly influence the activation of other immunohormonal messengers that modify immunity.
